A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis

Clinical trial NCT06457425 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06457425
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

MF,PMF,PPV-MF,PET-MF

Start date: 2024-05-06
Primary completion: 2025-11-26
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.